Who
Wendy L. Yarno
Director
Company insider
Files Form 4 as: Director, Tarsus Pharmaceuticals; Director, IDEAYA Biosciences; Director, Inovio Pharmaceuticals; Director, Iovance Biotherapeutics; Director, Global Blood Therapeutics; Director, MyoKardia; Director, Alder Biopharmaceuticals; Director, Aratana Therapeutics.
In numbers
- Trades disclosed
- 273
- Buys
- 2
- Sells
- 4
- Bought
- $100K
- Sold
- $12.0M
- Companies
- 12
- Companies where not an officer
- 11
- First trade
- 10 May 2006
- Last trade
- 15 Sep 2026
- Last filed
- 17 Sep 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 15 Sep 2026filed 17 Sep 2026 | TARS Tarsus PharmaceuticalsBiotechnology | SEC FORM 4 Code M | —302 | filing |
| 15 Sep 2026filed 17 Sep 2026 | TARS Tarsus Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code M | —302 at $0.00 | filing |
| 15 Sep 2026filed 17 Sep 2026 | TARS Tarsus Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code M | —302 at $0.00 | filing |
| 15 Sep 2026filed 17 Sep 2026 | TARS Tarsus PharmaceuticalsBiotechnology | SEC FORM 4 Code M | —302 | filing |
| 25 Jun 2026filed 29 Jun 2026 | TARS Tarsus Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —3,837 at $0.00 | filing |
| 25 Jun 2026filed 29 Jun 2026 | TARS Tarsus Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —2,417 at $0.00 | filing |
| 25 Jun 2026filed 29 Jun 2026 | TARS Tarsus Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —1,209 at $0.00 | filing |
| 25 Jun 2026filed 29 Jun 2026 | TARS Tarsus Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —3,837 at $0.00 | filing |
| 25 Jun 2026filed 29 Jun 2026 | TARS Tarsus Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —2,417 at $0.00 | filing |
| 25 Jun 2026filed 29 Jun 2026 | TARS Tarsus Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —1,209 at $0.00 | filing |
| 16 Jun 2026filed 18 Jun 2026 | IDYA IDEAYA Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —20,000 at $0.00 | filing |
| 16 Jun 2026filed 18 Jun 2026 | IDYA IDEAYA Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —20,000 at $0.00 | filing |
| 12 Jun 2026filed 16 Jun 2026 | TARS Tarsus PharmaceuticalsBiotechnology | SEC FORM 4 Code M | —2,954 | filing |
| 12 Jun 2026filed 16 Jun 2026 | TARS Tarsus Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code M | —2,954 at $0.00 | filing |
| 12 Jun 2026filed 16 Jun 2026 | TARS Tarsus Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code M | —2,954 at $0.00 | filing |
| 12 Jun 2026filed 16 Jun 2026 | TARS Tarsus PharmaceuticalsBiotechnology | SEC FORM 4 Code M | —2,954 | filing |
| 20 May 2026filed 21 May 2026 | INO Inovio Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —41,800 at $0.00 | filing |
| 20 May 2026filed 21 May 2026 | INO Inovio Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —34,200 at $0.00 | filing |
| 20 May 2026filed 21 May 2026 | INO Inovio Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —41,800 at $0.00 | filing |
| 20 May 2026filed 21 May 2026 | INO Inovio Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —34,200 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
Related people
Nobody else traded the same names lately.